Cite

HARVARD Citation

    Humrich, J. et al. (n.d.). A7.06 Low-dose IL-2 therapy in refractory sle: Insights from a phase I/IIA clinical trial. Annals of the rheumatic diseases. p. A58. [Online]. 
  
Back to record